OrthoPediatrics Corp. Launches New RESPONSE Rib and Pelvic Fixation System for EOS Scoliosis
04 Março 2024 - 6:05PM
OrthoPediatrics Corp. (“OrthoPediatrics” or the
“Company”) (Nasdaq: KIDS a company focused exclusively on advancing
the field of pediatric orthopedics, today announced it has launched
a new RESPONSE™ Rib and Pelvic Fixation system to treat children
with Early Onset Scoliosis (“EOS”). This represents the company’s
71st system to treat orthopedic conditions in pediatric patients.
This system represents OrthoPediatrics first
solution to treat Early Onset Scoliosis patients, and specifically
those associated with or at risk of Thoracic Insufficiency
Syndrome. The new addition to the RESPONSE™ family includes
implants and instruments for rib and pelvic fixation, and
associated devices to connect the fixation points. The system also
features a range of implant options, low profile implants, range of
motion rib hooks, and locking options to keep implants in place. As
an adjunct to the foundational RESPONSE™ Scoliosis System, the Rib
and Pelvic system is compatible with 5.5/6.0 and 4.5/5.0 RESPONSE™
Systems, allowing surgeons to treat the entire spectrum of patients
with scoliosis.
Greg Odle, President of the OrthoPediatrics’
Scoliosis Division echoed his excitement for the launch of this new
system, saying “We are excited to enter the Early Onset Scoliosis
treatment market with the RESPONSE™ Rib & Pelvic System. While
this is our first treatment option in the EOS market, we continue
to work with pediatric orthopedic surgeons to develop additional
treatment options for EOS patients.”
About OrthoPediatrics
Corp.Founded in 2006, OrthoPediatrics is an orthopedic
company focused exclusively on advancing the field of pediatric
orthopedics. As such it has developed the most comprehensive
product offering to the pediatric orthopedic market to improve the
lives of children with orthopedic conditions. OrthoPediatrics
currently markets 71 products that serve three of the largest
categories within the pediatric orthopedic market. This product
offering spans trauma and deformity, scoliosis, and sports
medicine/other procedures. OrthoPediatrics’ global sales
organization is focused exclusively on pediatric orthopedics and
distributes its products in the United States and over 70 countries
outside the United States. For more information, please visit
www.orthopediatrics.com.
Investor ContactPhilip Trip
Taylor Gilmartin Groupphilip@gilmartinir.com415-937-5406
OrthoPediatrics (NASDAQ:KIDS)
Gráfico Histórico do Ativo
De Out 2024 até Nov 2024
OrthoPediatrics (NASDAQ:KIDS)
Gráfico Histórico do Ativo
De Nov 2023 até Nov 2024